Historical record - last NADAC effective date: 1/18/2023
This NDC is on FDA's drug shortage list (posted Jan 19, 2023)
Reported reason: Shortage of an active ingredient
Product Information
QUINAPRIL 40 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0960 per EA under NDC 43547041309. Its NADAC has been published 305 times since Mar 14, 2018.
FDA first approved this application on Sep 15, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547041309
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
1/18/2023
Active Ingredients
QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205823FDA Approved
9/15/2016
TE Code
AB
On Market Since
3/16/2016
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL 40 MG TABLET has been published 305 times since Mar 14, 2018, and over the history we have for it it has declined 33.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0960 per EA |
|---|---|
| All-time high | $0.1439 (Mar 14, 2018) |
| All-time low | $0.0960 (Jan 18, 2023) |
| Median price | $0.1126 |
| Average price | $0.1130 |
| Largest weekly change | -10.7% (Jan 18, 2023) |
| Weeks tracked | 305 |
| Tracking since | Mar 14, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-14.0%
All
-33.2%
Last surveyed Jan 10, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the quinapril market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUINAPRIL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL 40 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0960 per EA (NDC 43547041309), effective Jan 10, 2024.
How has the price of QUINAPRIL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUINAPRIL 40 MG TABLET has declined 33.2%. It has been tracked across 305 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for QUINAPRIL 40 MG TABLET?
Since Mar 14, 2018, the NADAC for QUINAPRIL 40 MG TABLET has ranged from a low of $0.0960 (Jan 18, 2023) to a high of $0.1439 (Mar 14, 2018), with a median of $0.1126 per EA.
Are there cheaper alternatives to QUINAPRIL 40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL 40 MG TABLET?
QUINAPRIL 40 MG TABLET (NDC 43547041309) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Is QUINAPRIL 40 MG TABLET in shortage?
Yes — NDC 43547041309 is currently listed in FDA's drug shortage database (posted Jan 19, 2023). Reported reason: Shortage of an active ingredient.